Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

Bilateral Continuous Suprascapular Nerve Blocks for Bilateral Shoulder Hemiarthroplasty.

Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer.

Frailty Status and Outcomes After Transcatheter Aortic Valve Implantation.

Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.

Transcatheter Aortic Valve Implantation.

Inhospital and Post-discharge Changes in Renal Function After Transcatheter Aortic Valve Replacement.

Reliability and factor structure of the Hospital Anxiety and Depression Scale in a polytrauma clinic.

Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conference.

Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection.

Recovery brings uncertain future.

Fatal infectious pulmonary complications post-deceased donor renal transplantation.

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years.